Abstract
Background
The incidence of postoperative atrial fibrillation (POAF) after pulmonary lobectomy ranges from 6.4 to 12.6%. This study aimed to analyze the postoperative risk factors and prognosis for POAF in lobectomy for lung cancer.
Methods
Data were collected from patients undergoing pulmonary lobectomy from April 2010 to March 2019. We analyzed risk factors for POAF among perioperative factors and compared postoperative complications or overall survival between POAF and non-POAF groups. We classified POAF as either the temporary or non-temporary type and compared perioperative factors, postoperative complications, and overall survival.
Results
POAF was identified in 49 (5.2%) of the 947 lobectomies. The POAF group included more males, patients with poor performance status (PS), history of paroxysmal atrial fibrillation (AF), chronic obstructive pulmonary disease (COPD), and intraoperative blood transfusions. Poor PS, COPD, previous paroxysmal AF, and intraoperative blood transfusion were independent risk factors for POAF in multivariate analysis. The POAF group had a poorer prognosis than the non-POAF group (p = 0.0045). POAF was divided into 29 temporary and 20 non-temporary types. The onset date of non-temporary-type POAF was significantly later than that of the transient type (P < 0.01), and diabetes mellitus was significantly higher in non-temporary-type POAF. Non-temporary-type POAF had a significantly poorer prognosis in terms of overall survival (p = 0.005).
Conclusions
Poor PS, COPD, history of PAF, and intraoperative blood transfusion were independent risk factors for POAF. Non-temporary-type POAF occurred significantly later than transient type and caused poorer prognosis after lobectomy for lung cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Van Mieghem W, Tits G, Demuynck K et al (1996) Verapamil as prophylactic treatment for atrial fibrillation after lung operations. Ann Thorac Surg 61:1083–1086
Amar D, Roistacher N, Burt M et al (1995) Clinical and echocardiographic correlates of symptomatic tachydysrhythmias after noncardiac thoracic surgery. Chest 108:349–354
Onaitis M, D’Amico T, Zhao Y et al (2010) Risk factors for atrial fibrillation after lung cancer surgery: analysis of the society of thoracic surgeons general thoracic surgery database. Ann Thorac Surg 90:368–374
Muranishi Y, Sonobe M, Menju T et al (2017) Atrial fibrillation after lung cancer surgery: incidence, severity, and risk factors. Surg Today 47:252–258
Mita N, Kuroda M, Miyoshi S et al (2017) Association of preoperative right and left ventricular diastolic dysfunction with postoperative atrial fibrillation in patients undergoing lung surgery: a prospective observational study. J Cardiothorac Vasc Anesth 31:464–473
Amar D (2002) Perioperative atrial tachyarrhythmias. Anesthesiol 97:1618–1623
Roselli EE, Murthy SC, Rice TW et al (2005) Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg 130:438–444
Rami-Porta R, Bolejack V, Giroux DJ et al (2014) The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 9:1618–1624
Kawaguchi Y, Hanaoka J, Ohshio Y et al (2018) A risk score to predict postoperative complications after lobectomy in elderly lung cancer patients. Gen Thorac Cardiovasc Surg 66:537–542
Wann LS, Curtis AB, January CT et al (2011) 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 57:223–242
Israel CW, Grönefeld G, Ehrlich JR et al (2004) Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 43:47–52
Lee SH, Ahn HJ, Yeon SM et al (2016) Potentially modifiable risk factors for atrial fibrillation following lung resection surgery: a retrospective cohort study. Anaesthesia 71:1424–1430
Scridon A, Dobreanu D, Chevalier P et al (2015) Inflammation, a link between obesity and atrial fibrillation. Inflamm Res 64:383–393
Amar D, Burt M, Reinsel RA et al (1996) Relationship of early postoperative adysrhythmias and long-term outcomes after resection of non-small cell lung cancer. Chest 110:437–439
Imperatori A, Mariscalco G, Riganti G et al (2012) Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg 7:4
Garner M, Routledge T, King JE et al (2017) New-onset atrial fibrillation after anatomic lung resection: predictive factors, treatment and follow-up in a UK thoracic centre. Interact Cardiovasc Thorac Surg 24:260–264
Benjamin EJ, Wolf PA, D’Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circ 98:946–952
JCS Joint Working Group (2014) Guidelines for pharmacotherapy of atrial fibrillation. Circ J 78:1997–2021
Smith H, Yeung C, Gowing S et al (2018) A review and analysis of strategies for prediction, prevention and management of post-operative atrial fibrillation after non-cardiac thoracic surgery. J Thorac Dis 10:3799–3808
Acknowledgements
None
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ishibashi, H., Wakejima, R., Asakawa, A. et al. Postoperative Atrial Fibrillation in Lung Cancer Lobectomy—Analysis of Risk Factors and Prognosis. World J Surg 44, 3952–3959 (2020). https://doi.org/10.1007/s00268-020-05694-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-020-05694-w